Trials / Completed
CompletedNCT03440541
Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Egyptian Atomic Energy Authority · Other Government
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Using of human amniotic membrane extra-cellular matrix as a topical treatment for improving Psoriasis Area and Severity Index (PASI).
Detailed description
Human amniotic membrane extra-cellular matrix was purchased from National center for radiation research and technology, Egypt, under commercial name REGE pro gel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | REGE pro | REGE pro is a patch of human amniotic membrane sterilized by gamma radiation |
Timeline
- Start date
- 2015-08-04
- Primary completion
- 2016-02-13
- Completion
- 2016-04-08
- First posted
- 2018-02-22
- Last updated
- 2019-06-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03440541. Inclusion in this directory is not an endorsement.